Concepedia
Statistics
Publications
8
Citations
219
H-Index
Active since
2008
Affiliations
AbbVie (United States)(Current)
Abbott Fund
Abbott (United States)
Abbott (United Kingdom)
WuXi AppTec (China)
Dawn M. George is an author at AbbVie (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
2008–2018
Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit
Dawn M. George, Eric C. Breinlinger, Michael Friedman et al. · Journal of Medicinal Chemistry · 2014 · 44 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3
Martin E. Hayes, Grier A. Wallace, Pintipa Grongsaard et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 38 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
Optimized Protein Kinase Cθ (PKCθ) Inhibitors Reveal Only Modest Anti-inflammatory Efficacy in a Rodent Model of Arthritis
Dawn M. George, Eric C. Breinlinger, M.A. Argiriadi et al. · Journal of Medicinal Chemistry · 2014 · 32 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-α production
Kevin P. Cusack, Hamish Allen, Agnieszka K. Bischoff et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +7
Discovery of thieno[2,3-c]pyridines as potent COT inhibitors
Dawn M. George, Michael Friedman, Hamish Allen et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 26 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
1–5 of 8